Companies / Biocryst Pharmaceuticals Inc / Activity
Activity — Biocryst Pharmaceuticals Inc
25 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Stonehouse Jon P Director | Other | Common Stock | $2.64M | -306K -18.77% | 1,323,850 0.52% of shares | low |
| Mar 16, 2026 | Barnes Alane P Executive | Sell | Common Stock | $1.37M | -150K -27.24% | 400,703 0.16% of shares | medium |
| Mar 2, 2026 | Stonehouse Jon P Director | Exercise | Common Stock | $985.3K | +306K +23.11% | 1,629,845 0.64% of shares | low |
| Mar 16, 2026 | Barnes Alane P Executive | Exercise | Common Stock | $826.5K | +150K +37.43% | 550,703 0.22% of shares | low |
| Mar 20, 2026 | Heggie Theresa Director | Sell | Common Stock | $504.8K | -50K -43.31% | 65,352 0.03% of shares | medium |
| Mar 20, 2026 | Heggie Theresa Director | Exercise | Common Stock | $314.6K | +50K +76.41% | 115,285 0.05% of shares | low |
| Feb 27, 2026 | Frank Steven Director | Grant | Common Stock | $11.2K | +1K +7.29% | 18,903 <0.01% of shares | low |
| May 29, 2026 | Milano Vincent Director | Grant | Common Stock | $10.0K | +1K +1.22% | 93,189 0.04% of shares | low |
| Feb 27, 2026 | Milano Vincent Director | Grant | Common Stock | $7.4K | +848 +0.93% | 92,067 0.04% of shares | low |
| May 29, 2026 | Stonehouse Jon P Director | Grant | Common Stock | $5.6K | +631 +0.05% | 1,324,481 0.52% of shares | low |
| Feb 27, 2026 | McKee Amy E Director | Grant | Common Stock | $5.6K | +642 +1.54% | 42,432 0.02% of shares | low |
| Feb 27, 2026 | Milne Jill C. Director | Grant | Common Stock | $4.6K | +528 +3.55% | 15,382 <0.01% of shares | low |
| Feb 27, 2026 | Stonehouse Jon P Director | Grant | Common Stock | $3.7K | +421 +0.03% | 1,323,850 0.52% of shares | low |
| Jun 11, 2026 | Stonehouse Jon P Director | Grant | Common Stock | $0 | +15K +1.15% | 1,339,775 0.52% of shares | low |
| Jun 11, 2026 | Milano Vincent Director | Grant | Common Stock | $0 | +15K +16.41% | 108,483 0.04% of shares | low |
| Jun 11, 2026 | Levin Alan G Director | Grant | Common Stock | $0 | +15K +23.80% | 79,565 0.03% of shares | low |
| Jan 23, 2026 | Milne Jill C. Director | Grant | Common Stock | $0 | +12K +475.29% | 14,854 <0.01% of shares | low |
| Jun 11, 2026 | Stonehouse Jon P Director | Grant | Automatic Stock Option Grant | — | +34K | 33,540 0.01% of shares | low |
| Jun 11, 2026 | Milano Vincent Director | Grant | Automatic Stock Option Grant | — | +34K | 33,540 0.01% of shares | low |
| Jun 11, 2026 | Levin Alan G Director | Grant | Automatic Stock Option Grant | — | +34K | 33,540 0.01% of shares | low |
| Mar 20, 2026 | Heggie Theresa Director | Exercise | Automatic Stock Option Grant | — | -50K -100.00% | 0 0.00% of shares | low |
| Jan 23, 2026 | Milne Jill C. Director | Grant | Automatic Stock Option Grant | — | +27K | 26,684 0.01% of shares | low |
| Jan 23, 2026 | Milne Jill C. Director | Grant | Common Stock | — | +3K | 2,582 <0.01% of shares | low |
| Mar 16, 2026 | Barnes Alane P Executive | Exercise | Emp. Stock Option (Right to Buy) | — | -150K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Stonehouse Jon P Director | Exercise | Emp. Stock Option (Right to Buy) | — | -306K -100.00% | 0 0.00% of shares | low |